Login / Signup
Exploration of Lasmiditan 200 mg Versus 100 mg for the Treatment of Migraine: A Meta-analysis Based on Aggregate Data.
Ting Wang
Yimo Feng
Published in:
Clinical neuropharmacology (2024)
Lasmiditan 200 mg is more effective to improve pain free at 2 hours and 24 hours than lasmiditan 100 mg for the acute treatment of migraine patients.
Keyphrases
</>
end stage renal disease
newly diagnosed
liver failure
chronic kidney disease
machine learning
electronic health record
big data
intensive care unit
neuropathic pain
spinal cord injury
smoking cessation
mechanical ventilation